SA 878. Ms. SNOWE (for herself, Mr. Blumenthal, Mr. Schumer, Mr. Grassley, Mr. Casey, Ms. Klobuchar, Ms. Collins, Mr. Coons, Mr. Kirk, Mr. Wyden, Mr. Lautenberg, Mr. Brown, of Ohio, Mr. Sessions, and Mrs. Feinstein) submitted an amendment intended to be proposed to amendment SA 738 proposed by Mr. Inouye to the bill H.R. 2112, making appropriations for Agriculture, Rural
Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2012, and for other purposes; which was ordered to lie on the table; as follows:

On page 153, after line 24, add the following:
SEC. 218. REPORT ON COMBATING SYNTHETIC DRUGS.
(a) In General.--Using amounts made available under this Act, and not later than 90 days after the date of enactment of this Act, the Director of the Office of National Drug Control Policy, in coordination with the Attorney General, shall submit to the Committee on the Judiciary of the Senate and the Committee on the Judiciary of the House of Representatives a report detailing the strategy of the Federal Government for partnering with local law enforcement agencies to target the spread
of synthetic drugs, including methylenedioxypyrovalerone and mephedrone.
(b) Contents.--The report submitted under subsection (a) shall include the strategy of the Federal Government for--
(1) conducting public awareness campaigns and partnering with local law enforcement officials, hospitals, and schools to educate parents and young people about the dangers of abusing synthetic drugs;
(2) addressing the rampant abuse and ease of access of synthetic drugs in rural communities, where such problems can multiply quickly while attention is placed on larger population centers;
(3) using the High Intensity Drug Trafficking Areas program to provide additional assistance to law enforcement agencies operating in areas experiencing high levels of synthetic drug trafficking;
(4) improving coordination with U.S. Customs and Border Protection to seize shipments of synthetic drugs;
(5) developing and distributing test kits so that local law enforcement agencies can better identify dangerous individuals under the influence of synthetic drugs in the field; and
(6) using the authority under section 203 of the Controlled Substances Act (21 U.S.C. 813), to pursue law enforcement actions against the distribution of synthetic drugs.


(As printed in the Congressional Record for the Senate on Oct 19, 2011.)